Robert Bindert Huizinga - Sep 10, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
EVP of Research
Signature
/s/ Robert Bindert Huizinga
Stock symbol
AUPH
Transactions as of
Sep 10, 2021
Transactions value $
-$687,325
Form type
4
Date filed
9/14/2021, 05:12 PM
Previous filing
Sep 8, 2021
Next filing
Sep 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale -$99.2K -5K -3.61% $19.83 134K Sep 10, 2021 Direct F1
transaction AUPH Common Stock Sale -$98.8K -5K -3.74% $19.76 129K Sep 10, 2021 Direct F1
transaction AUPH Common Stock Sale -$489K -22.5K -17.5% $21.75 106K Sep 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.